glp 1 receptor agonist moa GLP-1 Agonists as Treatments for Type 2 Diabetes Glucagon-like peptide-1 receptor: mechanisms and
Description
Kidney Problems: GLP-1 medications can sometimes affect kidney function, especially in people with pre-existing kidney disease

GLP-1RA secondary to direct and mechanistic indirect effects on physiological systems have raised a need to further understand their potential in clinical practice

Nadkarni P, Chepurny OG, Holz GG

International Consensus Development International guidelines have shown similar evolution toward continuation with risk mitigation (Table 2)

Support hair health
